Form 4: Stryker Corp Executive Viju Menon Reports Stock Option Grant

Viju Menon, Group President at Stryker Corp, reports the grant of employee stock options.

Summary

• On February 5, 2025, Viju Menon, Group President of Stryker Corp, was granted employee stock options.
• These options, relating to 8,258 shares of common stock, were granted under the Stryker Corporation 2011 Long-Term Incentive Plan.
• The exercise price of the options is $392.39.
• The options vest in five equal installments, with 20% becoming exercisable on each of the first five anniversaries of the grant date.
• The options expire on February 4, 2035.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive. The granting of stock options is a standard practice and suggests confidence in the executive and the company's future performance. It's a routine filing, but positive for alignment of interests.

Positives

• The granting of stock options aligns the executive's interests with those of the shareholders, incentivizing performance and value creation.

Future Outlook

This Form 4 filing does not contain forward-looking statements about the company's future performance, but the granting of stock options suggests an expectation of continued growth and profitability.

Industry Context

Stock option grants are a common form of executive compensation in the medical device industry, aligning management's interests with shareholder value. Companies like Medtronic, Johnson & Johnson, and Boston Scientific also utilize stock options as part of their compensation packages.

Comparison to Industry Standards

• Stock option grants are a standard component of executive compensation packages in the medical device industry.
• Companies like Medtronic, Johnson & Johnson, and Boston Scientific use similar equity-based compensation plans to incentivize their executives.
• The vesting schedule of 20% per year over five years is a typical vesting structure.
• The specific number of options granted and the exercise price would need to be compared to similar roles at comparable companies to assess the competitiveness of the grant.

Stakeholder Impact

• Shareholders: The grant aligns executive interests with shareholder value.
• Employees: The grant may boost morale by demonstrating confidence in the company's leadership.

Key Dates